Factors leading to poor physical health in people with psychosis

Epidemiologia e Psichiatria Sociale

Volumn 13, Issue 3, 2004, Pages 141-145

  Samele, Chiara ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMORBIDITY; DIET; EDITORIAL; EXERCISE; HEALTH CARE QUALITY; HEALTH STATUS; HUMAN; LIFESTYLE; MENTAL HEALTH CARE; MORTALITY; PREVALENCE; PRIMARY PREVENTION; PSYCHOSIS; RISK FACTOR;

EID: 4644364707     PISSN: 1121189X     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1121189X00003407     Document Type: Editorial

References (55)

1. Addington J., el-Guebaly N., Addington D. & Hodgins, D. (1997). Readiness to stop smoking in schizophrenia. Canadian Journal of Psychiatry 42, 49-52.
2. Bartsch D.A., Shern D.L., Feinberg L.E., Fuller B. & Willett A. (1990). Screening CMHC outpatients for physical illness. Hospital and Community Psychiatry 41, 786-790.
3. Beecroft N., Becker T., Griffiths G., Leese M., Slade M. & Thornicroft G. (2001). Physical health care for people with severe mental illness: The role of the general practitioner (GP). Journal of Mental Health 10, 53-61.
4. Brown S. (1997). Excess mortality of schizophrenia. British Journal of Psychiatry 171, 502-508.
5. Brown S., Birtwhistle J. & Roe L. (1999). The unhealthy lifestyle of people with schizophrenia. Psychological Medicine 29, 697-701.
6. Brown S., Inskip H. & Barraclough B. (2000). Causes of the excess mortality of schizophrenia. British Journal of Psychiatry 177, 212-217.
7. Bunce D.F. 2nd, Jones L.R., Badger L. & Jones S.E. (1982) Medical illness in psychiatric patients: barriers to diagnosis and treatment. Southern Medical Journal 75, 941-944.
8. Davidson M. (2002). Risk of cardiovascular disease and sudden death in schizophrenia. Journal of Clinical Psychiatry 63, 5-11.
9. de Leon J. (1996). Smoking and vulnerability for schizophrenia. Schizophrenia Bulletin 22, 405-409.
10. Dickey B., Normand S.L.T., Weiss R.D., Drake R. & Azeni H. (2002). Medical morbidity, mental illness and sustance use disorders. Psychiatric Services 53, 861-867.
11. Drake R., Osher F. & Wallach M. (1989). Alcohol use and abuse in schizophrenia. A prospective community study. Journal of Nervous and Mental Disease 177, 408-414.
12. Dworkin R. (1994). Pain insensitivity in schizphrenia: A neglected phenomenon and some implications. Schizophrenia Bulletin 20, 235-248.
13. el-Guebaly N., Cathcart J., Currie S., Brown D. & Gloster S. (2002). Smoking cessation approaches for persons with mental illness or addictive disorders. Psychiatric Services 53, 1166-1170.
14. Felker B., Yazel J.J. & Short D. (1996). Mortality and medical comorbidity among psychiatric patients: A review. Psychiatric Services 47, 1356-1363.
15. George T.P., Ziedoni D., Feingold A., Pepper W., Satterburg C., Winkel J., Rounsaville B.J. & Kosten T.R. (2000). Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry 157, 1835-1842.
16. George T.P., Vessicchio J.C., Termine A., Bregartner T. A., Feingold A., Rounsaville B. J. & Kosten, T.R. (2002). A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biological Psychiatry 52, 53-61.
17. Goff D., Henderson D. & Amico E. (1992). Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. American Journal of Psychiatry 149, 1189-1194.
18. Goldman L. (1999). Medical illness in patients with schizophrenia. Journal of Clinical Psychiatry, Suppl. 21, vol. 60, pp.10-15.
19. Gralnick A. (1990). Nicotine addiction in the psychiatric hospital: Final report. Psychiatric Journal of the University of Ottawa 15, 165-168.
20. Halbreich U. & Palter S. (1996). Accelerated osteoporosis in psychiatric patients: Possible pathophysiological processes. Schizophrenia Bulletin 22, 447-454.
21. Hall R., Gardener E., Popkin M., Lecann A.F. & Stickney S.K. (1981). Unrecognised physical illness prompting psychiatric admission: a prospective study. American Journal of Psychiatry 138, 629-635.
22. Holmberg S. (1988). Physical health problems of the psychiatric client. Journal of Psychosocial Nursing and Mental Health Services 26, 35-39.
23. Honig A., Pop P., Tan E., Philipsen H. & Romme, M. (1989). Physical illness in chronic psychiatric patients from a community psychiatric unit. The implications for daily practice. British Journal of Psychiatry 155, 58-64.
24. Honig A., Pop P., de Kemp E., Philipsen H. & Romme, M. (1992). Physical illness in chronic psychiatric patients from a community psychiatric unit revisited. A three-year follow-up study. British Journal of Psychiatry 161, 80-83.
25. Hotopf M., Mayou R., Wadsworth M. & Wessely S. (1998). Temporal relationships between physical symptoms and psychiatric disorder. British Journal of Psychiatry 173, 255-261.
26. Hughes J., Hatsukami D., Mitchell J. & Dahlgren L. (1986). Prevalence of smoking among psychiatric outpatients. American Journal of Psychiatry 143, 993-997.
27. Jeste D., Gladsjo J., Lindamer L. & Lacro J. (1996). Medical comorbidity in schizophrenia. Schizophrenia Bulletin 22, 413-427.
28. Karasu T., Waltzman S., Lindermayer J. & Buckley P. (1980). The medical care of patients with psychiatric illness. Hospital and Community Psychiatry 31, 463-472.
29. Kendrick T. (1996). Cardiovascular and respiratory risk factors and symptoms among General Practice patients with long-term mental illness. British Journal of Psychiatry 169, 733-739.
30. Koran L., Sox H., Marton K., Moltzen S., Sox C., Kraemer H., Imai K., Kelsey T.G., Rose T.G. Jr, Levin L.C., et al. (1989.) Medical evaluation of psychiatric patients. I. Results in a state mental health system. Archives of General Psychiatry 46, 733-740.
31. Koro C.E., Fedder D.O., L'Italien G.J., Weiss S.S., Magder L.S., Kreyenbuhl J., Revicki D.A. & Buchanan R.W. (2002). Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study. British Medical Journal 325, 243-247.
32. Lader M. (1999). Some adverse effects of antipsychotics: Prevention and treatment. Journal of Clinical Psychiatry 60, 18-21.
33. Lambert T.J.R., Velakoulis D. & Pantelis C. (2003). Medical comorbidity in schizophrenia. Medical Journal of Australia 178, Suppl. 5, 567-570.
34. Lawrence D., Holman C., Jablensky A. & Hobbs M. (2003). Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980-1998. British Journal of Psychiatry 182, 31-36.
35. Levy M. (1996). Asthmatic patients with psychosis need special care. British Medical Journal 312, 82-83.
36. Lichtermann D., Ekelund J., Pukkala E., Tanskanen A. & Lonnqvist J. (2001). Incidence of cancer among persons with schizophrenia and their relatives. Archives of General Psychiatry 58, 573-578.
37. Lyketsos C., Dunn G., Kaminsky M. & Breakey W. (2002). Medical comorbidity in psychiatric inpatients. Relation to clinical outcomes and hospital length of stay. Psychosomatics 43, 24-30.
38. McChargue D., Gulliver S. & Hitsman B. (2002). Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment? Addiction 97, 785-793.
39. McCreadie R., MacDonald E., Blacklock C., Tilah-Singh D., Wiles D. & Halliday J. (1998). Dietary intake of schizophrenia patients in Nithsdale, Scotland: Case-control study. British Medical Journal, 784-785.
40. McEnvoy J., Freudenreich O. & Wilson W. (1999). Smoking and therapeutic response to clozapine in patients with schizophrenia. Biological Psychiatry 46, 125-129.
41. Menezes P., Johnson S., Thornicroft G., Marshall J., Prosser D., Bebbington P. & Kuipers E. (1996). Drug and alcohol problems among individuals with severe mental illnesses in South London. British Journal of Psychiatry 168, 612-619.
42. Meyer J. M. (2002). A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: Metabolic outcomes after 1 year. Journal of Clinical Psychiatry 63, 425-433.
43. Mirza I. & Phelan M. (2002). Managing physical illness in people with severe mental illness. Hospital Medicine 63, 535-539.
44. Mortensen P. & Juel K. (1993). Mortality and causes of death in first admitted schizophrenic patients. British Journal of Psychiatry 163, 183-189.
45. Phelan M., Stradins L. & Morrison S. (2001). Physical health of people with severe mental illness. British Medical Journal 322, 443-444.
46. Reiger D., Farmer M., Rae D., Locke B., Keith S., Judd L. & Goodwin F. (1990). Comorbididty of mental disorders with alcohol and other drug abuse. Journal of the American Medical Association 264, 2511-2518.
47. Ringback Weitoft G., Gullberg A. & Rosen M. (1998). Avoidable mortality among psychiatric patients. Social Psychiatry and Psychiatric Epidemiology 33, 430-437.
48. Ruschena D., Mullen P., Burgess P., Cordner S., Barry-Walsh J., Drummer O., Palmer S., Browne C. & Wallace C. (1998). Sudden death in psychiatric patients. British Journal of Psychiatry 172, 331-336.
49. Rutstein D., Berenberg W., Chalmers T., Child C.G. 3rd, Fishman A.P. & Perrin E.B. (1976). Measuring the quality of medical care. A clinical method. New England Journal of Medicine 294, 582-588.
50. Seymour L. (2003). Not All in the Mind: the Physical Health of Mental Health Service Users. Mentality: London.
51. Strakowski S., Tohen M., Stoll A., Faedda G., Mayer P., Kolbrener M. & Goodwin D. (1993). Comorbidity in psychosis at first hospitalization. American Journal of Psychiatry, 752-757.
52. Taylor D. & McAskill R. (2000). Aytypical antipsychotics and weight gain - a systematic review. Acta Psychiatrica Scandinavica 101, 416-432.
53. Tsuang M., Perkins K. & Simpson J. (1983). Physical diseases in schizophrenia and affective disorder. Journal of Clinical Psychiatry 44, 42-46.
54. Wieck A. & Haddad P. (2002). Hyperprolactinaemia caused by antipsychotic drugs. British Medical Journal 324, 250-252.
55. Ziedonis D., Kosten T. R., Glazier W. & Frances R. (1994). Nicotine dependence and schizophrenia. Hospital and Community Psychiatry 45, 204-206.